News

The Play On Legend Biotech
Legend Biotech faces a 60% stock drop amid safety, supply issues, and competition for its CAR-T therapy, Carvykti. See here ...
‘Super antibodies’ for snake toxins: how a dangerous DIY experiment helped scientists make a new antivenom
A man spent 18 years injecting himself with venom, almost dying more than once – and now his blood is behind a new snakebite ...
Antibodies that recognize lipids: A new path for HIV vaccines and autoimmune disease treatments
Lipids are the fatty molecules that make up cellular membranes, creating a protective barrier that regulates what enters and ...
Chimeric brain models can help bridge the gap between animal studies and human neurological disorders
A specialized model used by researchers is becoming a valuable tool for studying human brain development, diseases and ...
AlphaGalileo7d
Novel CAR-T Cells Specifically Targeting Nectin4 Exhibit Effective Anti-Tumor Efficacy in Bladder Cancer Cell Lines
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
TMCnet12d
BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025
Highlights of BioNTech’s oncology programs to be presented at AACR 2025: ...
mayo20d
KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person Syndrome
If anti-GAD65 antibodies are lower than the high titer threshold peripherally but positive in the cerebrospinal fluid (CSF), the subject can be included. A prior documented high titer anti-GAD65 ...
Frontiers20d
Isolation of human monoclonal antibodies from 4CMenB vaccinees reveals PorB and LOS as the main OMV components inducing cross-strain protection
Methods: Following the isolation of plasmablasts from vaccinees, the OMV-specific human monoclonal antibodies (HumAbs) were recombinantly expressed and characterized for their binding and functional ...
The American Journal of Managed Care27d
52-Week MINT Data Confirm Inebilizumab Benefit in AChR+ gMG: Richard Nowak, MD, MS
Why is that important? B cells are the factories of antibody production, and they're also the factories of pathogenic autoantibody production. In approximately 80% of patients with generalized ...